SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Unichem Laboratories informs about notice of board meeting & trading window closure

23 Sep 2024 Evaluate

Pursuant to the Company’s Code of Conduct to Regulate, Monitor and Report Trading by Insiders, formulated and adopted under the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, Unichem Laboratories has informed that the Trading Window for dealing in shares of the Company will be closed for Designated Persons, Directors, Insiders and their Immediate Relatives from Monday, 23rd September 2024 in view of the meeting of the Board of Directors of the Company scheduled to be held on Monday, 30th September 2024 to consider, integration and consolidation of the generics formulations business in the US market of Bayshore Pharmaceuticals LLC (wholly owned subsidiary of Company’s holding company, Ipca Laboratories) into Unichem Pharmaceuticals (USA) Inc. (company’s wholly owned subsidiary) so as to consolidate all the Ipca Group’s USA generics formulations business under one entity. The window closure will continue from 1st October 2024 till 48 hours after declaration of financial results of the Company for the quarter and half year ended 30th September 2024 for Designated Persons, Directors, Insiders and their Immediate Relatives.

The above information is a part of company’s filings submitted to BSE.

Unichem Lab Share Price

350.85 4.85 (1.40%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×